Roman DBDR (NASDAQ: DRDB) gets Nasdaq warning on too few holders
Rhea-AI Filing Summary
Roman DBDR Acquisition Corp. II (DRDB) reports that The Nasdaq Stock Market has notified the company that it is not in compliance with Nasdaq Listing Rule 5450(a)(2), which requires a minimum of 400 holders for continued listing on the Nasdaq Global Market. Nasdaq’s Deficiency Notice does not immediately affect the listing of the company’s units, Class A ordinary shares, or warrants. Roman DBDR Acquisition Corp. II has 45 calendar days, until October 5, 2026, to submit a compliance plan. If Nasdaq accepts the plan, it may grant up to 180 calendar days from the date of the notice, until February 15, 2027, for the company to regain compliance, with a right to appeal if the plan is not accepted.
Positive
- None.
Negative
- Nasdaq listing deficiency: The company is not in compliance with Nasdaq Listing Rule 5450(a)(2) due to having fewer than 400 holders, creating a risk of eventual delisting if it cannot regain compliance within the 45–180 day remediation window.
Insights
Analyzing...
8-K Event Classification
2 items: 3.01, 9.01
2 items
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Securities
The company received a delisting notice, failed to satisfy a continued-listing rule or standard, or transferred its listing.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Minimum holders required under Nasdaq Listing Rule 5450(a)(2): 400 holders
Initial plan submission period: 45 calendar days (until October 5, 2026)
Maximum exception period: 180 calendar days (until February 15, 2027)
3 metrics
Minimum holders required under Nasdaq Listing Rule 5450(a)(2)
400 holders
Requirement for continued listing on the Nasdaq Global Market
Initial plan submission period
45 calendar days (until October 5, 2026)
Time allowed to submit a plan to regain compliance after the August 19, 2026 Deficiency Notice
Maximum exception period
180 calendar days (until February 15, 2027)
Potential extension to regain compliance if Nasdaq accepts the plan
Key Terms
Nasdaq Listing Rule 5450(a)(2), Deficiency Notice, Nasdaq Global Market, Nasdaq Hearings Panel
4 terms
Nasdaq Listing Rule 5450(a)(2) regulatory
"not in compliance with the requirements of Nasdaq Listing Rule 5450(a)(2)"
Deficiency Notice regulatory
"received a deficiency letter (the “Deficiency Notice”) from the Listing Qualifications"
A deficiency notice is a formal letter from a regulator, stock exchange, or securities authority saying that a company’s required filing, disclosure, or compliance item is missing, incomplete, or does not meet rules. It matters to investors because it can delay deals or financial reports, signal higher regulatory or operational risk, and reduce confidence in a company’s transparency—similar to getting a repair notice that must be fixed before normal activity can resume.
Nasdaq Global Market market
"continued listing of the Company’s securities on The Nasdaq Global Market"
The Nasdaq Global Market is a section of the stock exchange where larger, well-established companies are listed and publicly traded. It functions like a marketplace where investors can buy and sell shares of these companies, providing them with access to capital and opportunities for growth. Its role is important because it helps investors identify and invest in reputable companies with strong financial backgrounds.
Nasdaq Hearings Panel regulatory
"the opportunity to appeal that decision to a Nasdaq Hearings Panel"
A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.
FAQ
What Nasdaq compliance issue did Roman DBDR Acquisition Corp. II (DRDB) report?
Roman DBDR Acquisition Corp. II reported that Nasdaq notified it of non-compliance with Nasdaq Listing Rule 5450(a)(2) because it does not have the required minimum of 400 holders needed to maintain its listing on the Nasdaq Global Market.
Does the Nasdaq deficiency notice immediately affect DRDB’s listing?
No. The company states that the Deficiency Notice has no immediate effect on the listing of its units, Class A ordinary shares, or warrants on the Nasdaq Global Market.
How long does DRDB have to submit a plan to regain Nasdaq compliance?
Roman DBDR Acquisition Corp. II has 45 calendar days from the August 19, 2026 Deficiency Notice, or until October 5, 2026, to submit a plan to Nasdaq to regain compliance with Nasdaq Listing Rule 5450(a)(2).
What extension can Nasdaq grant DRDB to regain compliance?
If Nasdaq accepts the company’s plan, it may grant an exception of up to 180 calendar days from the August 19, 2026 notice, or until February 15, 2027, for Roman DBDR Acquisition Corp. II to regain compliance with Nasdaq Listing Rule 5450(a)(2).
Can DRDB appeal if Nasdaq rejects its compliance plan?
Yes. If Nasdaq does not accept the company’s compliance plan, Roman DBDR Acquisition Corp. II would have the opportunity to appeal that decision to a Nasdaq Hearings Panel, according to the disclosure.
AI-generated analysis. How Rhea-AI works. Not financial advice.
